← All Topics / owner-education

Plain-language: Are isoxazoline flea-and-tick drugs (the four brothers) safe? (EN+ZH)

owner_education_isoxazoline_plain

owner-education 400 tok en 2026-08-16

EN — For pet owners. Afoxolaner, fluralaner, sarolaner and lotilaner are all isoxazoline-class agents — the four common flea-and-tick pills/chews. They work the same way: they block insect and acarine GABA- and glutamate-gated chloride channels, killing fleas and ticks. Their US FDA adverse-event report totals differ hugely: Fluralaner: 88486, Sarolaner: 79692, Afoxolaner: 69037, Lotilaner: 13432. The source notes Seizure NOS appears in every brother — a class-wide neurological signal in the reports. Two cautions: *"Lack of efficacy"* terms denote product-performance reports (the product didn't kill the parasite) and must not be read as toxicity; and reported ≠ causal. Bottom line — report counts differ mostly with exposure breadth; a filed report is not proof of harm.

中文 — 给宠物主人。 Afoxolaner, fluralaner, sarolaner and lotilaner are all isoxazoline-class agents——四种常见异噁唑啉类驱虫药。作用机制相同:they block insect and acarine GABA- and glutamate-gated chloride channels, killing fleas and ticks.(阻断跳蚤蜱虫的氯离子通道将其杀死。)四者在美国 FDA 不良事件报告总数差别很大:Fluralaner: 88486Sarolaner: 79692Afoxolaner: 69037Lotilaner: 13432。源文指出 Seizure NOS appears in every brother(四种的报告里都出现癫痫条目,是全类共有的神经学信号)。两点注意:*"Lack of efficacy"* terms denote product-performance reports (the product didn't kill the parasite)("无效"类术语是产品性能报告,不能当成毒性);且 reported ≠ causal(有报告 ≠ 有因果)。结论——报告数量差异主要反映使用面广度;有报告不等于证明有害。

Source article: isoxazoline-four-brothers-ade (built from C1-verified openFDA source topics).

Claims (verified as substrings of the C1-verified source article)

  • Afoxolaner, fluralaner, sarolaner and lotilaner are all isoxazoline-class agents
  • they block insect and acarine GABA- and glutamate-gated chloride channels, killing fleas and ticks.
  • Fluralaner: 88486
  • Sarolaner: 79692
  • Afoxolaner: 69037
  • Lotilaner: 13432
  • Seizure NOS appears in every brother
  • *"Lack of efficacy"* terms denote product-performance reports (the product didn't kill the parasite)
  • reported ≠ causal

Sources

Isoxazoline-class ectoparasiticides adverse-event reporting — plain-language owner summary
Source document: Isoxazoline-class ectoparasiticides adverse-event reporting — plain-language owner summary
FDA CVM openFDA (via source article)derived from isoxazoline-four-brothers-aderetrieved 2026-08-16

Verification file: web/articles/articles/isoxazoline-four-brothers-ade.md